Impact of a Commercial Reference Laboratory Test Recurrence Score on Decision Making in Early-Stage Breast Cancer

Por Oratz, Ruth, Paul, Dev, Cohn, Allen L., Sedlacek, Scot M.
Publicado em 2007

BRAF(V600) mutations in solid tumors, other than metastatic melanoma and papillary thyroid cancer, or multiple myeloma: a screening study

Por Cohn, Allen L, Day, Bann-Mo, Abhyankar, Sarang, McKenna, Edward, Riehl, Todd, Puzanov, Igor
Publicado no Onco Targets Ther (2017)

Treatment Patterns and Clinical Outcomes in Patients With Metastatic Colorectal Cancer Initially Treated with FOLFOX–Bevacizumab or FOLFIRI–Bevacizumab: Results From ARIES, a Bevac...

Por Bendell, Johanna C., Bekaii-Saab, Tanios S., Cohn, Allen L., Hurwitz, Herbert I., Kozloff, Mark, Tezcan, Haluk, Roach, Nancy, Mun, Yong, Fish, Susan, Flick, E. Dawn, Dalal, Darshan, Grothey, Axel
Publicado em 2012

A Phase II Randomized Trial (GO27827) of First‐Line FOLFOX Plus Bevacizumab with or Without the MET Inhibitor Onartuzumab in Patients with Metastatic Colorectal Cancer

Por Bendell, Johanna C., Hochster, Howard, Hart, Lowell L., Firdaus, Irfan, Mace, Joseph R., McFarlane, Joshua J., Kozloff, Mark, Catenacci, Daniel, Hsu, Jessie J., Hack, Stephen P., Shames, David S., Phan, See‐Chun, Koeppen, Hartmut, Cohn, Allen L.
Publicado no Oncologist (2017)

Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer

Por Borad, Mitesh J., Reddy, Shantan G., Bahary, Nathan, Uronis, Hope E., Sigal, Darren, Cohn, Allen L., Schelman, William R., Stephenson, Joe, Chiorean, E. Gabriela, Rosen, Peter J., Ulrich, Brian, Dragovich, Tomislav, Del Prete, Salvatore A., Rarick, Mark, Eng, Clarence, Kroll, Stew, Ryan, David P.
Publicado no J Clin Oncol (2015)